ClinicalTrials.gov
ClinicalTrials.gov Menu

Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01485055
Recruitment Status : Active, not recruiting
First Posted : December 5, 2011
Last Update Posted : March 3, 2017
Sponsor:
Information provided by (Responsible Party):
Rajinder Bajwa, Nationwide Children's Hospital